CABOMETYX

Swiss trademark · 699534 · Combined mark · In force

Register entry

Registration number
699534
Application number
59180/2016
Status
In force
Type
Combined mark
As registered
CABOMETYX ((fig.))
Filed
Aug 2, 2016
Registered
Mar 6, 2017
Published
Mar 6, 2017
Protected until
Aug 2, 2036
Priority
03.03.2016 US
Language of procedure
German
Vienna classes
25.05.05, 26.03.04, 26.03.06, 26.03.24
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Krebs, Schmerzen, Infektionen, Entzündungen, hormonelle Störungen, Knochenstörungen und mentalen Störungen; Analgetika; Hormone für medizinische Zwecke; Psychopharmaka; Präparate gegen Infektionserreger; entzündungshemmende Mittel; Präparate zur Krebsbekämpfung.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 13, 2026

    Renewed

    Expiry date
    02.08.2026 → 02.08.2036

    Published in Swissreg on 13.04.2026

  2. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  3. Aug 14, 2019

    Licensee entered

    Exclusive licensee
    Ipsen Pharma SAS, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France

    Published in Swissreg on 14.08.2019

  4. Aug 13, 2019

    Holder’s address changed

    Owner
    Exelixis, Inc., 210 East Grand Avenue, South San Francisco, CA 94080, USA → Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, CA 94502, USA

    Published in Swissreg on 13.08.2019

  5. Mar 6, 2017

    Registered

    Published in Swissreg on 06.03.2017

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.